KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $17,232,000 | +1086.0% | 95,837 | +195.7% | 0.15% | +1158.3% |
| Q4 2016 | $1,453,000 | -6.4% | 32,413 | +16.6% | 0.01% | -25.0% |
| Q3 2016 | $1,552,000 | -63.4% | 27,789 | -67.2% | 0.02% | -46.7% |
| Q2 2016 | $4,237,000 | +3.7% | 84,746 | -4.8% | 0.03% | +3.4% |
| Q1 2016 | $4,086,000 | -22.5% | 89,004 | +4.0% | 0.03% | -21.6% |
| Q4 2015 | $5,272,000 | +6.5% | 85,550 | -3.7% | 0.04% | +23.3% |
| Q3 2015 | $4,949,000 | +86.9% | 88,879 | +104.6% | 0.03% | +76.5% |
| Q2 2015 | $2,648,000 | +212.3% | 43,437 | +195.3% | 0.02% | +240.0% |
| Q1 2015 | $848,000 | -8.3% | 14,710 | -8.3% | 0.01% | 0.0% |
| Q4 2014 | $925,000 | +575.2% | 16,048 | +234.3% | 0.01% | +400.0% |
| Q3 2014 | $137,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |